<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03354338</url>
  </required_header>
  <id_info>
    <org_study_id>UIBObosque</org_study_id>
    <nct_id>NCT03354338</nct_id>
  </id_info>
  <brief_title>Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy</brief_title>
  <acronym>AMX-Perio</acronym>
  <official_title>Efficacy of Intensive Periodontal Therapy and Premedication With Oral Amoxicilline on Inflammatory Markers and Bacteremia in Patients With Chronic Periodontitis. A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad El Bosque, Bogotá</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad El Bosque, Bogotá</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are not published studies evaluating the incidence, nature, magnitude and/or duration
      of bacteremia after periodontal treatment. The pre-surgical antibiotics have been studied
      particullary over Gram positive bacterial but not over gram negative bacterial and their
      secondary effects over the systemic pro-inflamation. Objective: to evaluate the efficacy of
      intensive periodontal therapy and pre-medication with oral amoxicilline on inflammatory
      bio-markers and the incidence, duration and magnitude of bacteremia in patients with chronic
      periodontitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, triple-blind clinical trial with 90 participants will be conducted (age
      range18-65 years) with chronic periodontitis will be received and intensive periodontal
      therapy under local anaesthesia. Participants will be randomly assigned using block
      randomization in two groups. Test group premedication with 2 gr of oral amoxicilline 1 hour
      before periodontal treatment and control group with 2 gr of placebo 1 hour before treatment.
      High-sensitivity assays will be used to quantify serum concentrations of inflammatory marker
      (Interleukin (IL-1β), Interleukin 6, Tumour necrosis factor α, MCP 1, C Reactive Protein
      (CRP), plasma haemostatic (D-dimer), and von Willebrand factor antigen (r-WF:Ag).

      Samples of blood will be taken at baseline (before treatment), inmediatly finished the
      treatment, 30 minutes and 1, seven and 30 days after treatment to asses bacteremia and
      inflammatory markers.

      Bacterial isolation and identification: Bacterial colonies will be isolated on both selective
      and nonselective culture medium for aerobes and anaerobes bacteria. Sensitive Digital
      quantitative polymerase chain reaction will be used to quantify bacteria.

      Concentrations of CPRus, inflammatory, haemostatic and endotellial cell activation markers
      will be quantified by high-sensitive enzyme liked inmunosorbent assays according to the
      manufacturer´s protocol. For each cytokine, comparisons between groups will be made by time.
      The levels of cytokines expressed in picograms will be transformed into international units
      for the statistical analysis.

      In case it follows a normal distribution, an analysis of variance (ANOVA) for repeated
      measurements between groups with post hoc corrections made by Wilcoxon test will be used. In
      case it doesn´t follow a normal distribution, Non parametric test such as Friedman´s test
      will be used. Values of p&lt;0.05 will be accepted as statiscally significant.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 21, 2017</start_date>
  <completion_date type="Anticipated">July 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A triple-blind randomized controlled trial with 90 participants will be conducted. Participants will be assigned using block randomization in two groups and will received intensive periodontal therapy under local anaesthesia.
Test group pre-medication with 2 gr of oral amoxicilline 1 hour before treatment.
Control group with 2 gr of placebo 1 hour before treatment. Samples of blood will be taken at baseline (before treatment), immediately finished the treatment, 30 minutes later, after 24 hours, after seven days and on the day 30th to asses bacteremia and inflammatory markers</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Participant, care provider, Investigator, Outcomes Assessor and Statistic. The treatment codes of the study were not accessible to the investigators and to the examiner until the data will be analyzed.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence bacteria &quot;Change&quot;</measure>
    <time_frame>baseline (before treatment), immediately finished the treatment, 30 minutes later, after 24 hours, after seven days and on the day 30th</time_frame>
    <description>absence or presence bacterial in blood</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Nature of the bacteria</measure>
    <time_frame>baseline (before treatment), immediately finished the treatment, 30 minutes later, after 24 hours, after seven days and on the day 30th</time_frame>
    <description>bacterial strain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of magnitude of bacteremia</measure>
    <time_frame>baseline (before treatment), immediately finished the treatment, 30 minutes later, after 24 hours, after seven days and on the day 30th</time_frame>
    <description>Colony forming units (CFU)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of bacteremia</measure>
    <time_frame>baseline (before treatment), immediately finished the treatment, 30 minutes later, after 24 hours, after seven days and on the day 30th</time_frame>
    <description>Bacteremia´s minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of levels of Interleukin</measure>
    <time_frame>baseline, immediately finished the treatment, 30 minutes, 24 hours, 7 days and day 30th later</time_frame>
    <description>Levels pg/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of C Reactive Protein (CRP)</measure>
    <time_frame>baseline, immediately finished the treatment, 30 minutes, 24 hours, 7 days and day 30th later</time_frame>
    <description>Levels mg/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of levels of plasma haemostatic (D-dimer)</measure>
    <time_frame>baseline, immediately finished the treatment, 30 minutes, 24 hours, 7 days and day 30th later</time_frame>
    <description>Levels ng/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of von Willebrand factor antigen (r-WF:Ag)</measure>
    <time_frame>baseline, immediately finished the treatment, 30 minutes, 24 hours, 7 days and day 30th later</time_frame>
    <description>Levels ng/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Pressure blood</measure>
    <time_frame>baseline, immediately finished the treatment</time_frame>
    <description>Millimeter of mercury (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Heart rate.</measure>
    <time_frame>baseline, immediately finished the treatment</time_frame>
    <description>Beats per Minute (BPM)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Chronic Periodontitis</condition>
  <condition>Bacteremia</condition>
  <arm_group>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intensive Periodontal treatment and pre-medication with 2 gr of oral amoxicilline 1 hour before treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PLACEBO</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intensive Periodontal treatment with 2 gr of Placebo 1 hour before treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin</intervention_name>
    <description>Intensive Periodontal treatment; Pre-medication with 2 gr of oral Amoxicillin 1 hour before treatment</description>
    <arm_group_label>Experimental Group</arm_group_label>
    <other_name>Intensive Periodontal treatment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Intensive Periodontal treatment; Pre-medication with 2 gr of Placebo 1 hour before treatment</description>
    <arm_group_label>PLACEBO</arm_group_label>
    <other_name>Intensive Periodontal treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with chronic periodontitis (Ameriacam Academy of Periodontology 2015), having
             at least 2 teeth for quadrant with periodontal probing pockets depth ≥ 5 mm.

        Exclusion Criteria:

          -  Pregnant and lactating women, Diabetes, hypertension, Obesity, Allergy to penicillin,
             consumption of systemic antimicrobial or anti-inflamatory drugs in the last 2 months,
             Autoimmune diseases, patients with medical conditions that required antibiotic
             premedication such as prosthetic heart valve replacement, skeletal joint replacement,
             previous history of infective endocarditis and history of rheumatic fever.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis Antonio Noriega Frontado, MSc (c)</last_name>
    <role>Principal Investigator</role>
    <affiliation>El Bosque University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Luis Antonio Noriega Frontado</name>
      <address>
        <city>Bogotá</city>
        <state>Bogotá D.C</state>
        <zip>1101</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <reference>
    <citation>American Academy of Periodontology Task Force Report on the Update to the 1999 Classification of Periodontal Diseases and Conditions. J Periodontol. 2015 Jul;86(7):835-8. doi: 10.1902/jop.2015.157001. Epub 2015 May 27.</citation>
    <PMID>26125117</PMID>
  </reference>
  <reference>
    <citation>Arduino PG, Tirone F, Schiorlin E, Esposito M. Single preoperative dose of prophylactic amoxicillin versus a 2-day postoperative course in dental implant surgery: A two-centre randomised controlled trial. Eur J Oral Implantol. 2015 Summer;8(2):143-9.</citation>
    <PMID>26021225</PMID>
  </reference>
  <reference>
    <citation>Axelsson P, Nyström B, Lindhe J. The long-term effect of a plaque control program on tooth mortality, caries and periodontal disease in adults. Results after 30 years of maintenance. J Clin Periodontol. 2004 Sep;31(9):749-57.</citation>
    <PMID>15312097</PMID>
  </reference>
  <reference>
    <citation>Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol. 1996 Oct;67(10 Suppl):1123-37. Review.</citation>
    <PMID>8910831</PMID>
  </reference>
  <reference>
    <citation>Castillo DM, Sánchez-Beltrán MC, Castellanos JE, Sanz I, Mayorga-Fayad I, Sanz M, Lafaurie GI. Detection of specific periodontal microorganisms from bacteraemia samples after periodontal therapy using molecular-based diagnostics. J Clin Periodontol. 2011 May;38(5):418-27. doi: 10.1111/j.1600-051X.2011.01717.x. Epub 2011 Mar 11.</citation>
    <PMID>21392048</PMID>
  </reference>
  <reference>
    <citation>Cobb CM. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol. 2002 May;29 Suppl 2:6-16. Review.</citation>
    <PMID>12010523</PMID>
  </reference>
  <reference>
    <citation>D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J. 2006 May;151(5):977-84.</citation>
    <PMID>16644317</PMID>
  </reference>
  <reference>
    <citation>D'Aiuto F, Parkar M, Tonetti MS. Acute effects of periodontal therapy on bio-markers of vascular health. J Clin Periodontol. 2007 Feb;34(2):124-9. Epub 2007 Jan 3.</citation>
    <PMID>17214734</PMID>
  </reference>
  <reference>
    <citation>Daly CG, Mitchell DH, Highfield JE, Grossberg DE, Stewart D. Bacteremia due to periodontal probing: a clinical and microbiological investigation. J Periodontol. 2001 Feb;72(2):210-4.</citation>
    <PMID>11288795</PMID>
  </reference>
  <reference>
    <citation>Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015 Mar 28;385(9974):1219-28. doi: 10.1016/S0140-6736(14)62007-9. Epub 2014 Nov 18.</citation>
    <PMID>25467569</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2017</study_first_submitted>
  <study_first_submitted_qc>November 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2017</study_first_posted>
  <last_update_submitted>November 21, 2017</last_update_submitted>
  <last_update_submitted_qc>November 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad El Bosque, Bogotá</investigator_affiliation>
    <investigator_full_name>Luis Antonio Noriega Frontado</investigator_full_name>
    <investigator_title>MSc (c) Dentistry Science</investigator_title>
  </responsible_party>
  <keyword>Periodontal disease</keyword>
  <keyword>Bacteremia</keyword>
  <keyword>Amoxicilline</keyword>
  <keyword>Inflamatory markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
    <mesh_term>Bacteremia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

